News

Ten years after Emanuel AME Church shootings stunned people across country, a look at lessons learned from tragic event and aftermath.

With $26.5 million in new funding, SCTR will clear the way for the translation of research breakthroughs into clinics and communities.

Doctoral candidate Amber Hazzard has been named one of 17 AAAS Mass Media Fellows for 2025.

The Moodivate app improved depression symptoms significantly more than usual care treatment in a clinical trial at 22 MUSC Health primary care practices.

“There's an incredible amount of excitement about this device.” MUSC prepares to place totally under-the-skin cochlear implants in patients with hearing loss.

Neuropsychologist at MUSC is a senior author with a team that linked importance of new brain cells with verbal memory and intellectual functioning.

An international collaboration has advanced therapies for co-occurring substance use disorders and PTSD and helped to inform prevention efforts globally.

Electronic health record-based screening for intimate partner violence prioritizes confidentiality.

Hollings was part of an international clinical trial that led to the FDA approval of a new drug to treat certain types of gliomas.

External evaluation of MUSC’s telestroke program confirms that stroke center certification and stroke coordinators improve stroke-care metrics.